ARK Investment Management LLC 13D and 13G filings for Pacific Biosciences of California, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 4:01 pm Purchase | 2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | ARK Investment Management LLC | 34,504,273 12.900% | 8,812,592 (+34.30%) | Filing |
| 2023-02-10 1:48 pm Sale | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | ARK Investment Management LLC | 25,691,681 11.360% | -691,422 (-2.62%) | Filing |
| 2022-02-09 2:45 pm Sale | 2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | ARK Investment Management LLC | 26,383,103 11.960% | -2,121,526 (-7.44%) | Filing |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | ARK Investment Management LLC | 28,504,629 15.320% | 8,659,849 (+43.64%) | Filing |
| 2020-10-09 2:00 pm Purchase | 2020-09-30 | 13G | Pacific Biosciences of California, Inc. PACB | ARK Investment Management LLC | 19,844,780 11.230% | 19,844,780 (New Position) | Filing |